Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

How to design and launch a successful Clinical Trial Manufacturing.

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial supply, ...

The reference process involved triple plasmid transfection ... The team, which discovered that the model predicted trends in viral vector formation but struggled to fit the cell density data ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

Yet, the complexity of scaling viral vector processes to commercial levels ... case study of a helper-dependent adenovirus (HDAd) process from bench scale and optimization, to a successful scale ...

As an executive leader at OXB James held overall responsibility for a range of key functions including Programme and Alliance Management, Process ... prolific academic viral vector manufacturing ...